X4 Pharmaceuticals (XFOR) Competitor Comparison
We are evaluating the key criteria listed to compare X4 Pharmaceuticals (XFOR) against its competitors in the Biotechnology industry.
Market Capitalization
235 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
213 / 337Free Cashflow
216 / 352Quick Ratio
170 / 357Earnings per Share
93 / 359Dividend yield
0 / 5Total Cash
188 / 358Performance 3 years
309 / 368Performance 5 years
331 / 368Performance 10 years
334 / 368Linearity 3 years
298 / 368Linearity 5 years
288 / 368Linearity 10 years
307 / 368Total Rank
68 / 368Dividend Rank
313 / 368Valuation Rank
245 / 368Piotroski Rank
245 / 368Muliplier Rank
91 / 368Market Capitalization - XFOR ranking 235 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.